PMC:7307149 / 4209-4619
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T25 | 59-72 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 59-72 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T37 | 112-120 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T38 | 164-172 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T39 | 290-299 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T43 | 23-25 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
| T44 | 59-72 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
| T45 | 148-150 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T46 | 209-215 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T47 | 301-303 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
| T48 | 365-367 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
| T49 | 403-405 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
| T50 | 406-408 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 103 | 164-172 | Species | denotes | SARS-CoV | Tax:694009 |
| 104 | 177-185 | Species | denotes | MERS-CoV | Tax:1335626 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T34 | 0-410 | Sentence | denotes | Other similarities (20–22), including genomic (23, 24) and immune system response (25–33) similarities, between SARS-CoV-2 and other coronaviruses (34), especially SARS-CoV and MERS-CoV, are topics of ongoing active research, results of which may inform an understanding of the severity of infection (35) and improve the ongoing work of immune landscape profiling (36–40) and vaccine discovery (28, 37, 41–48). |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32303592-32143502-65501623 | 20-22 | 32143502 | denotes | 20 |
| 32303592-32027036-65501624 | 47-49 | 32027036 | denotes | 23 |
| 32303592-32007145-65501625 | 51-53 | 32007145 | denotes | 24 |
| 32303592-32105090-65501626 | 83-85 | 32105090 | denotes | 25 |
| 32303592-32092539-65501627 | 301-303 | 32092539 | denotes | 35 |
| 32303592-32106567-65501628 | 395-397 | 32106567 | denotes | 28 |